Minnelide synergizes with conventional chemotherapy by targeting both cancer and associated stroma components in pancreatic cancer-Reference-Cited by-同舟云学术

Minnelide synergizes with conventional chemotherapy by targeting both cancer and associated stroma components in pancreatic cancer

Published:2022-07 Issue: Volume:537 Page:215591
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Modi Shrey,Giri Bhuwan,Gupta Vineet K.,Lavania Shweta,Sethi Vrishketan,Sharma Nikita S.^ORCID,Pandey Somnath,Vickers Selwyn,Dudeja Vikas,Saluja Ashok K.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference59 articles.

1. Cancer statistics, 2021;Siegel;CA Cancer J Clin,2021

2. Recent progress in pancreatic cancer;Wolfgang;CA Cancer J Clin,2013

3. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine;Von Hoff;N. Engl. J. Med.,2013

4. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer;Conroy;N. Engl. J. Med.,2011

5. Defining eligibility of FOLFIRINOX for first-line metastatic pancreatic adenocarcinoma (MPC) in the Province of British Columbia: a Population-based retrospective study;Ho;Am. J. Clin. Oncol.,2015

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Significance of Phytoconstituents in Modulating Cell Signalling Pathways for the Treatment of Pancreatic Cancer;Revista Brasileira de Farmacognosia;2024-09-13

2. The safety and efficacy outcomes of Minnelide given alone or in combination with paclitaxel in advanced gastric cancer: A phase I trial;Cancer Letters;2024-08

3. Inhibition of autophagy induced by tetrandrine promotes the accumulation of reactive oxygen species and sensitizes efficacy of tetrandrine in pancreatic cancer;Cancer Cell International;2024-07-10

4. Antitumor mechanisms and future clinical applications of the natural product triptolide;Cancer Cell International;2024-04-27

5. Dual activity of Minnelide chemosensitize basal/triple negative breast cancer stem cells and reprograms immunosuppressive tumor microenvironment;2024-02-22